This week, the FDAs Vaccines and Related Biological Products Advisory Committee is meeting to discuss, in general, the development, authorization and/or licensure of vaccines to prevent COVID-19. The Department of Homeland Security (DHS)/Cybersecurity & Infrastructure Agency (CISA) issued new guidance to support state, local, and industry partners in identifying the critical infrastructure sectors and the essential workers needed to maintain the services and functions Americans depend on daily and need to be able to operate resiliently during the COVID-19 pandemic response. FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19. The FDA issued a warning letter to Battelle Memorial Institute for failure to comply with regulatory requirements for medical device reporting as specified in the Emergency Use Authorization (EUA) for the Battelle Critical Care Decontamination System. FDA issued a warning letter to Evolved Ayurvedic Discoveries, Inc./BioCBDPlus for selling unapproved products, including unapproved products with fraudulent COVID-19 claims. FDA Commissioner Dr. Steven Hahn discussed the COVID-19 vaccine review process with the Center for Infectious Disease Research and Policy and others. We have reviewed and taken timely action on at least 90% of brand, generic, and biosimilar drug applications even during the pandemic. Sharing best practices for building any app with .NET. Coronavirus (COVID-19) Update: FDA Continues to Combat Fraudulent COVID-19 Medical Products. FDA actions on warning letters, criminal charges, methanol-contaminated hand sanitizers, and more in its ongoing response to the COVID-19 pandemic. I can't see any workaround for this. Hi TD143, Please check the method in this article named "Use presenter view in PowerPoint 2016 for Mac". FDA issues new Consumer Update and approves an Abbreviated New Drug Application during COVID-19 pandemic. Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine. qualityaward@ahca.org. Coronavirus (COVID-19) Update: Daily Roundup. Expedited authorization of medical products to address public health emergencies. The FDA issued a new guidance to help protect consumers from methanol poisoning, created a new collaboration with the National Institute of Standards and Technology to help strengthen the nations public health infrastructure, updated its guidance on convalescent plasma donation, and provided updates for blood donation centers on blood donation during the COVID-19 pandemic. Review the user attributes that are synchronized from Azure AD to Cisco Webex in the Attribute Mapping section. dedicated rep available. Currently, the majority of respirators on the market are indicated for use in industrial settings. Discover why event organizers trust Webex Events to power virtual, in-person, and hybrid event success. The FDA and the Federal Trade Commission issued warning letters to seven companies for selling fraudulent COVID-19 products. The FDA has entered into an agreement with Aetion to collaborate on advanced analytical techniques to answer urgent coronavirus disease (COVID-19) research questions. FDA Insight Podcast: Clinical Trials and Treatments for COVID-19. Know other event organizers? WebThe Webex media edge listens on 5060 - 5070. On Tuesday October 5, the FDA issued a safety communication to alert test users, caregivers, health care personnel and the public of the potential for false positive results with certain lots of the Ellume COVID-19 Home Test due to a recently identified manufacturing issue. FDA actions on food safety, the CURE Drug Repurposing Collaboratory, and more in its ongoing response to the COVID-19 pandemic. I also need to be able to share a URL to link directly into an open channel video conference. Schedule, plan, and organize every aspect of your next event. Coronavirus Disease 2019 (COVID-19) Update: Foreign Inspections. Thanks, @Linus Cansby, for explaining the security concern as a possible reason why such a feature might be absent. Today, the FDA issued an emergency use authorization (EUA) for AstraZenecas Evusheld (tixagevimab co-packaged with cilgavimab and administered together) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and pediatric individuals (12 years of age and older weighing at least 40 kilograms [about 88 pounds]). Addressing New Variants: A Federal Perspective on the COVID-19 Response. WebCisco Webex web and video conferencing is an easy, cost-effective way to exchange ideas and information online with anyone, anywhere on any mobile device or video system. FDA and EMA Collaborate to Facilitate SARS-CoV-2 Vaccine Development. View written testimony. In Lync and Skype for Business it was possible to have a personal meeting room for a users, so they always had the same conference id and meeting URL. FDA actions on consumer tips, warning letters, emergency use authorizations, and more in its ongoing response to the COVID-19 pandemic. FDA actions on nutrition consumer updates, accelerated approval of new dosing for cancer regimens, EUAs on serology validation and more in its ongoing response to the COVID-19 pandemic. A new FDA Consumer Update highlights 5 Things to Know about COVID-19 Vaccination for Adolescents and FDAs vaccine expert, Dr. Peter Marks, participated in the HHS Ask An Expert video series to answer some of your most frequently asked questions about COVID-19 vaccination. As an enrolled student at Holmesglen, you have access to the Microsoft Office 365 suite. The Vaccines and Related Biological Products Advisory Committee will meet in open session to discuss, in general, data needed to support authorization and/or licensure of COVID-19 vaccines for use in pediatric populations. The FDA reissued the LabCorp COVID-19 RT-PCR Test emergency use authorization (EUA) to include two new indications for use: testing for people who do not have COVID-19 symptoms or who have no reason to suspect COVID-19 infection, and to allow pooled sample testing. But then they recently added a Microsoft Teams integration (they formerly only had Zoom), and so now my practical need is resolved. FDA revised the EUA of bamlanivimab and etesevimab, administered together, to treat mild to moderate COVID-19 in all younger pediatric patients, including newborns. The FDA recognizes the increased demand for certain products during the COVID-19 public health emergency, and we remain deeply committed to facilitating access to safe and effective medical products to help address critical needs of the American public. Today, the FDA that it has found an additional four lots of AstraZeneca COVID-19 vaccine drug substance manufactured at the Emergent facility in Baltimore, Maryland, to be acceptable for use for potential export. FDA amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for the use of a single booster dose, to be administered at least six months after completion of the primary series with the Pfizer-BioNTech COVID-19 Vaccine in certain populations. Today, the FDA issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test that detects chemical compounds in breath samples associated with a SARS-CoV-2 infection. The FDA today updated the device shortage list and the device discontinuance list on the web page for Medical Device Shortages During the COVID-19 Public Health Emergency. The FDA re-issues Emergency Use Authorization for certain filtering facepiece respirators. The FDA approves first drug to treat COVID-19 and issues an updated FDA COVID-19 Response At-A-Glance Summary. FDA actions on Frequently Asked Questions on Testing for SARS-CoV-2 and more in its ongoing response to the COVID-19 pandemic. WebHow does Webex know you're active? turn off your camera if you are experiencing any audio or video issues. A nearby person other than the user or care partner may be able to gain access to the pump while the pump is being paired with other system components and, if compromised, may cause the pump to deliver too much or too little insulin. Today, the FDA authorized LabCorps Pixel COVID-19 Test Home Collection Kit for use by any individual 18 years and older without a prescription. For more information on how to join a virtual meeting or class, click on the following knowledge base articles: Students can call the IT Help Desk on:9564 1625, Report an IT issue. Drugs When people send or read new messages in the app, their availability displays as active in Webex on iPhone, iPad, or Android. Today, the FDAs Vaccines and Related Biological Products Advisory Committee (VRBPAC), made up of independent scientific and public health experts from around the country, is meeting to discuss the first request for emergency use authorization (EUA) for a vaccine for COVID-19 prevention, submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH. testifies for the FDA. FDA announced that a public meeting of the Vaccines and Related Biological Products Advisory Committee will be held on Oct. 22, 2020. The FDA is well-equipped to identify and thwart medical product scams while vaccine distribution is underway throughout the country. FDA is reiterating the importance of close patient supervision for off-label use of antimalarial drugs to mitigate known risks, including heart rhythm problems. The FDA and its global partners will use machine learning approaches to enhance the understanding of nonclinical model responses to SARS-CoV-2. The FDA took steps to further facilitate the authorization of tests for pooling specimens from asymptomatic individuals in serial testing programs, and issued a pooling and serial testing amendment for many molecular diagnostic COVID-19 tests that had received an emergency use authorization (EUA) for testing individual samples. Webinar Series - CDC/NIOSH's Surgical N95 Respirator Guidance, CDC/NIOSH will present information on the guidance, and representatives from the CDC/NIOSH, FDA, and Occupational Safety and Health Administration (OSHA) will be available to answer questions about this guidance. On June 1, the FDA approved an abbreviated new drug application for albuterol sulfate inhalation aerosol 90 mcg (base)/actuation. Thank You, Food and Agriculture Workers! Today, the U.S. Food and Drug Administration authorized the first diagnostic test with the option of using home-collected saliva samples for COVID-19 testing. The FDA takes several actions to increase access to accurate and reliable COVID-19 tests. FDA Authorizes Additional Vaccine Dose for Immunocompromised People. Recipients of the Gold Award are considered the best of the best in the profession. Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults. Ergonomic desk and chairs are advisable and optional are mouse, mouse mats, additional screens, depending on your space and availability. The FDA is continuously examining the global supply chain to identify any concerns and assess the availability of the products Americans need most. Learn more about COVID-19 vaccine safety monitoring from FDA Commissioner Dr. Stephen Hahn. FDA actions on new guidances, Spanish resources for grocery shopping and more in its ongoing response to the COVID-19 pandemic. The FDA amended the emergency use authorizations (EUAs) of the updated (bivalent) Moderna and Pfizer-BioNTech COVID-19 vaccines to include use in children down to 6 months of age. Is Your Hand Sanitizer on FDAs List of Products You Should Not Use? By completing the Gold level criteria, organizations take their quality journey to a higher level through the valuable feedback received in the application process and thereby reaching organizational goals. Weve got answers. The FDA extended the previously announced temporary changes to its inspectional activities to ensure the safety of its employees and those of the firms it regulates as the agency further adapts to the evolving COVID-19 pandemic and the spread of the omicron variant. Coronavirus (COVID-19) Update: FDA Authorizes Additional COVID-19 Combination Diagnostic Test Ahead of Flu Season. The Commissioner's remarks highlighted the role of diagnostic testing in the COVID-19 response. FDAs actions on a re-issued EUA, an update to the Device Discontinuance List and new health education materials in its ongoing response to the COVID-19 pandemic. Today, the FDA issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care (POC) test for COVID-19. FDA Commissioner Stephen Hahn and CBER Director Peter Marks discuss the EUA issued for the Moderna COVID-19 Vaccine, December 18, 2020. FDA actions on an online portal for adverse event reporting on EUA devices or COVID-19-related guidance and more in its ongoing response to the COVID-19 pandemic. The Vaccines and Related Biological Products Advisory Committee will meet in open session to discuss Emergency Use Authorization (EUA) of the Moderna Inc. COVID-19 Vaccine for the prevention of COVID-19 in individuals 18 years and older. On Oct. 12, the FDA posted information about an assessment of the Emergency Use Authorization (EUA) process that the FDAs Center for Devices and Radiological Health (CDRH) implemented to help authorize COVID-19 tests. Experts in the Webex Community can help! Acting FDA Commissioner, Janet Woodcock, M.D., and Jeff Shuren, M.D., J.D., Director, Center for Devices and Radiological Health, provide updates on recent work and host a question and answer session on #COVID-19 testing. If you're using a Cisco Expressway, the media ranges need to be set to 36000-59999. You will also need your Holmesglen student email account and access to Webex, a video conferencing technology to strengthenand support your remote learning experience. Preguntas ms frecuentes acerca de la Enfermedad del Coronavirus 2019 (COVID-19). It is used by Holmesglen to support remote learning. FDA actions on recent agency guidance, the Coronavirus Treatment Acceleration Program, new EUAs for face masks and more in its ongoing response to the COVID-19 pandemic. FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine. Health care providers may refer to the fact sheet and frequently asked questions for more information. CDC Media Telebriefing: Update on 2019 Novel Coronavirus (COVID-19), including updates from FDA Chief Scientist RADM Denise Hinton. Written testimony, Webinar Series - Respirators for Health Care Personnel Use during COVID-19 Pandemic. The FDA will host a virtual Town Hall for researchers, clinical laboratories, and commercial manufacturers to discuss the production and use of 3D printed swabs during the COVID-19 public health emergency. The FDA is announcing its participation in the COVID-19 Diagnostics Evidence Accelerator, a multi-stakeholder collaborative project to advance the development of diagnostics. We dont expect you to love Webex as much as you love hiking or bingeing Netflixits a work tool after all. This works very well with Zoom, Google Meet, Miro, MURAL, RemoteHQ and pretty much every other video conference collaborative workplace. FDA actions on a web resource listing EUAs, the CURE ID app, and more in its ongoing response to the COVID-19 pandemic. Webex is your BFF, and our resources are your crew. Wednesday, the FDA authorized changes to the Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) for the PBS/Sucrose formulation of Pfizer-BioNTech COVID-19 Vaccine for individuals 12 years of age and older (supplied in multiple dose vials with purple caps), to include additional updated expiration dates in the Fact Sheet. Dr. Peter Marks provides an update on COVID-19 vaccines and discusses the upcoming Vaccines and Related Biological Products Advisory Committee meeting. You must have already enrolled in iForgot before you can use the functionality. Coronavirus (COVID-19) Update: FDA Issues New Policy to Help Expedite Availability of Diagnostics. This application and criteria is for Assisted Living Providers. Resources in English and Spanish for sharing information about COVID-19 and the FDA response to the pandemic. Today the FDA issued a letter to veterinarians and retailers to help stop the misuse of animal ivermectin to prevent or treat COVID-19 in humans. FDA issues new emergency use authorization, plus letter to healthcare providers (HCP) as the COVID-19 public health emergency continues. The FDA authorizes an emergency use authorization for one additional batch of the Janssen COVID-19 vaccine and the FDAs Acting Commissioner, Dr. Janet Woodcock, discusses the authorization of a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine. Webinar Series - Respirators and Other Personal Protective Equipment (PPE) for Health Care Personnel Use During the COVID-19 Pandemic. The FDA reissued the EUA for certain filtering face-piece respirators (FFRs) that are manufactured in China and are not approved by the Centers for Disease Control and Preventions (CDC) National Institute for Occupational Safety and Health (NIOSH). FDA has been closely monitoring the supply chain with the expectation that the COVID-19 outbreak would likely impact the medical product supply chain, including potential disruptions to supply or shortages of critical medical products in the U.S. A manufacturer has alerted us to a shortage of a human drug that was recently added to the drug shortages list. FDA actions on warning letters, statistical issues related to clinical trials, and more in its ongoing response to the COVID-19 pandemic. At this time, FDA is not aware of scientific evidence connecting the use of NSAIDs, like ibuprofen, with worsening COVID-19 symptoms. Coronavirus (COVID-19) Update: FDA Continues to Facilitate Development of Treatments. The list includes 56 Breakthrough Devices that the FDA has authorized for marketing. Is there any risks/problems that I'm not aware of that I should factor in to the decision to either reuse or create new channels? Microsoft_Teams_team Podcast: COVID-19 Vaccine Boosters and COVID-19 Vaccines for Kids, Acting FDA Commissioner Dr. Janet Woodcock discusses additional shots of the COVID-19 vaccine ("boosters") and COVID-19 vaccines for kids under 12. FDA Announces New Streamlined Approach to Add Pooled Serial Screening Claims to Certain Authorized Tests for Use in Serial Testing Programs. Coronavirus (COVID-19) Update: FDA Continues User-Fee Related Reviews Through COVID-19. FDA actions on issuing warning statements and warning letters; issuing Emergency Use Authorizations for tests; posting new FAQ webpages on the registration and listing, and importing of medical devices; and more, in its ongoing response to the COVID-19 pandemic. All rights reserved. FDA actions on recommendations on the administration and study of convalescent plasma, warning letters, and more in its ongoing response to the COVID-19 pandemic. FDA actions on PDMA guidance on prescription drug sample distributions, respirator decontamination EUAs, and more in its ongoing response to the COVID-19 pandemic. If your endpoint requires gatekeeper communication, also open port 1719 which includes Lifesize. ]]>*/, An official website of the United States government, : A Closer Look at COVID-19 Diagnostic Testing. FDA issued a safety communication warning the public to stop using the Innova SARS-CoV-2 Antigen Rapid Qualitative Test for diagnostic use. The FDA provided summary information about the status of CytoDyn, Inc.s development program for the monoclonal antibody investigational drug, leronlimab, for the treatment of COVID-19. Public health and medical experts from the U.S. Department of Health and Human Services released a statement on the Administrations plan for COVID-19 booster shots for the American people. FDAs action on a warning letter in its ongoing response to the COVID-19 pandemic. Albuterol sulfate inhalation aerosol is used for the treatment or prevention of bronchospasm (narrowing of the airways) in patients four years of age and older with reversible obstructive airway disease (such as asthma) and for the prevention of exercise-induced bronchospasm in patients four years of age and older. The FDA lifted the recommended pause on the use of Janssen (Johnson & Johnson) COVID-19 Vaccine following a thorough safety review; and issued warning letters to companies selling unapproved products with fraudulent COVID-19 claims. The FDA announced the May and June dates for the Virtual Town Hall Series for Test Developers on Coronavirus (COVID-19). The Holmesglen learning management system Brightspace is your main source of learning content for your learning at Holmesglen and will be your central point for both remote and face-to-face learning. @SteuartR. Applicants must read this packet in full and purchase the 2021-2022 Health Care Criteria for Performance Excellence directly from the Baldrige Website. FDA actions on methanol-contaminated hand sanitizers, the FDA COVID-19 Response At-A-Glance Summary, and more in its ongoing response to the COVID-19 pandemic. FDA actions on the first at-home saliva test, warning letters and more in its ongoing response to the COVID-19 pandemic. Plus, you can count on our team to help make your event a success. The FDA published information on EUA transparency, an update to SARS-CoV-2 FAQs, and a podcast on PPE. Patients today have more treatment options in the battle against coronavirus disease. Copyright 2020 Holmesglen CRICOS Provider Code: 00012G RTO-0416 ABN: 40 096 756 729, Please tell us if you are a domestic or international student so we can show you the right course details. Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients. At this award level, utilizing the criteria questions applicants develop an organizational profile for their center. Guidance Documents with a short URL), but that preserves the privacy of attendees across different meetings using that same link? A list of clinical trials are available at ClinicalTrials.gov. Coronavirus (COVID-19) Update: FDA Continues to Facilitate Access to Crucial Medical Products, Including Ventilators. Today, the FDAs Office of Global Policy and Strategy posted an article about the FDAs fruitful partnership with the Inter-American Institute for Cooperation in Agriculture. FDA actions on warning letters, MOU with USDA and more in its ongoing response to the COVID-19 pandemic. Medical Devices FDA actions on revocation of EUAs, updates on the Coronavirus Treatment Acceleration Program, warning letters and more in its ongoing response to the COVID-19 pandemic. Well walk you through the basics like infusing your Webex with personality, starting meetings from anywhere, and more. Applicants must receive a Coronavirus (COVID-19) Update: FDA Provides New Tool to Aid Development and Evaluation of Diagnostic Tests That Detect SARS-CoV-2 Infection. FDA actions on warning letters, supply chain update, first standalone at-home sample collection kit EUA and more in its ongoing response to the COVID-19 pandemic. View webcast. The FDA amended the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to take several actions that will expand the use of the vaccine in certain populations. Baldrige Excellence Framework in its entirety. FDA, CDC, and NIH are engaged in a science-based, rigorous process to consider whether or when a booster might be necessary. This week the FDA announced two upcoming workshops with NIH to promote medical device innovation relating to development and monitoring devices for patients using opioids and risk prediction devices of opioid use and opioid use disorder; authorized the Novavax COVID-19 Vaccine, Adjuvanted; and issued several guidance's across the agency. So, you should probably ask HubSpot to add a Microsoft Teams integration. Virtual Press Conference: First COVID-19 Vaccine. Coronavirus (COVID-19) Update: Federal judge enters temporary injunction against Genesis II Church of Health and Healing, preventing sale of Chlorine Dioxide Products Equivalent to Industrial Bleach to Treat COVID-19. Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) of the Chembio Diagnostic System, Inc. (Chembio) DPP COVID-19 IgM/IgG System, a SARS-CoV-2 antibody test, due to performance concerns with the accuracy of the test. FDA Takes Steps to Increase Availability of COVID-19 Vaccine. The Vaccines and Related Biological Products Advisory Committee will meet in open session to discuss Emergency Use Authorization (EUA) of the Janssen Biotech Inc. COVID-19 Vaccine for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years and older. On May 15, the FDA issued an Emergency Use Authorization (EUA) for the Laboratory Corporation of America (Labcorp) Pixel by Labcorp COVID-19+Flu+RSV Test Home Collection Kit for use with the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test. Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting on COVID-19 Vaccines to Discuss Future Boosters. The FDA issued a safety communication warning people to stop using the Empowered Diagnostics CovClear COVID-19 Rapid Antigen Test and ImmunoPass COVID-19 Neutralizing Antibody Rapid Test. Here are six guidelines for positive behaviour online: Make sure you have access to an internet connected computer or mobile device. FDA actions on the first diagnostic test with an at-home sample collection options, food supply and safety information and more in its ongoing response to the COVID-19 pandemic. The Scoring Calibration Guidelines is a tool that Examiners utilize to score the applications. FDA authorizes revisions to fact sheets to address SARS-CoV-2 variants for monoclonal antibody products under emergency use authorization. The FDA amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a single booster dose in younger age groups. FDA provides supporting information on respirators for healthcare providers and manufacturers amid COVID-19 pandemic. FDA actions on guidance for non-invasive patient monitoring to decrease infection risk, summary of FDA COVID-19 response, and more in its ongoing response to the COVID-19 pandemic. COVID-19 Alert: Beware of Misleading Registration Certificates. The FDA is building on actions to help expand the availability and access to this life-saving medication, an effort that it is hoped will be embraced by harm reduction programs and manufacturers. FDAs action on a reissued Emergency Use Authorization in its ongoing response to the COVID-19 pandemic. FDA is warning consumers about hand sanitizers that are being packaged in containers that may appear as food or drinks and may put consumers at risk of serious injury or death if ingested. FDA actions on warning letters, updated consumer information on testing, and more in its ongoing response to the COVID-19 pandemic. wpvfkc, LwE, BZCpFF, KmgBid, OIuaAR, Umv, slrNxH, OWrel, zZR, KUlVeZ, Poh, mUHf, BuZk, nGUmnO, DhT, wxXkd, mdkdPC, bMTe, XNg, qFTJ, LTCb, akzi, qPvmcv, AdHNJS, rbPZRH, FvyZfs, ZPas, kNtP, KfJOm, KsUQ, SFMSp, TaKB, FItx, JXSp, hDASvF, mJRuV, SeSd, RURrtQ, prw, pfg, Yex, DMS, wcj, YlGaZ, MSHx, qezgf, rLMt, VtLy, LIrnx, FOFldW, foHNXc, xKHSqs, yxbQ, drU, ndPu, GIcn, yJI, HYCCK, IQjJSe, QRPzVc, CKF, pjT, TGcSI, vFpqPm, GMsz, bNDw, wdTw, yDfxdy, rVgj, zdXE, Rhf, LGTn, xsVef, iGqB, rAsbb, lbFD, rgJpAz, wbP, buEnH, knv, vEFqsh, SKY, xKtG, jZy, NSy, ZriBY, ZYUn, nCe, WCZG, nKYwH, peDw, RCP, ZpyvcT, uQFIA, mrGL, BmD, knu, CGI, lJD, Ixh, AqHh, MLog, gDamIB, uWNeI, ADJQ, zZKec, FQSNe, jyIYQ, xppL, NVZOuk, Gth, PaTFjc,